Combivent - Ipratropium with salbutamol
Boehringer Ingelheim
Description
Ipratropium with short-acting selective beta2 agonist.
For adult: 0.5/2.5 mg 3–4 times a day.
Indications
For the treatment of bronchospasm in COPD.
Preparations Available
Nebuliser liquid
Sizes Available
Nebuliser fluid
Combivent, salbutamol 1 mg/ml, ipratropium 200 mcg/ml, 2.5 ml, 60 vials
More on: Bronchodilators , Short-acting selective beta2: agonists